These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 24819660

  • 1. Women with a partial mole during their first pregnancy and diagnosed earlier in gestation are at increased risk of developing gestational trophoblastic neoplasia.
    Worley MJ, Joseph NT, Berkowitz RS, Goldstein DP.
    Int J Gynecol Cancer; 2014 Jun; 24(5):941-5. PubMed ID: 24819660
    [Abstract] [Full Text] [Related]

  • 2. Effect of race/ethnicity on clinical presentation and risk of gestational trophoblastic neoplasia in patients with complete and partial molar pregnancy at a tertiary care referral center.
    Gockley AA, Joseph NT, Melamed A, Sun SY, Goodwin B, Bernstein M, Goldstein DP, Berkowitz RS, Horowitz NS.
    Am J Obstet Gynecol; 2016 Sep; 215(3):334.e1-6. PubMed ID: 27130239
    [Abstract] [Full Text] [Related]

  • 3. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
    Braga A, Maestá I, Matos M, Elias KM, Rizzo J, Viggiano MG.
    Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
    [Abstract] [Full Text] [Related]

  • 4. Postmolar gestational trophoblastic neoplasia: beyond the traditional risk factors.
    Bakhtiyari M, Mirzamoradi M, Kimyaiee P, Aghaie A, Mansournia MA, Ashrafi-Vand S, Sarfjoo FS.
    Fertil Steril; 2015 Sep; 104(3):649-54. PubMed ID: 26099850
    [Abstract] [Full Text] [Related]

  • 5. Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia?
    Braga A, Biscaro A, do Amaral Giordani JM, Viggiano M, Elias KM, Berkowitz RS, Seckl MJ.
    Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():50-55. PubMed ID: 29477553
    [Abstract] [Full Text] [Related]

  • 6. Gestational trophoblastic neoplasia after human chorionic gonadotropin normalization in a retrospective cohort of 7761 patients in France.
    Descargues P, Hajri T, Massardier J, Lotz JP, Devouassoux-Shisheboran M, Allias Montmayeur F, You B, Golfier F, Bolze PA.
    Am J Obstet Gynecol; 2021 Oct; 225(4):401.e1-401.e9. PubMed ID: 34019886
    [Abstract] [Full Text] [Related]

  • 7. Linear regression of postevacuation serum human chorionic gonadotropin concentrations predicts postmolar gestational trophoblastic neoplasia.
    Lybol C, Sweep FC, Ottevanger PB, Massuger LF, Thomas CM.
    Int J Gynecol Cancer; 2013 Jul; 23(6):1150-6. PubMed ID: 23714707
    [Abstract] [Full Text] [Related]

  • 8. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
    Gueye M, Kane-Gueye SM, Ndiaye-Gueye MD, Mbaye M, Diouf AA, Niang MM, Diallo M, Moreau JC.
    BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
    [Abstract] [Full Text] [Related]

  • 9. PTEN and MDM2 expression in the prediction of postmolar gestational trophoblastic neoplasia.
    Lertkhachonsuk R, Tantbirojn P, Paiwattananupant K.
    J Reprod Med; 2012 Oct; 57(7-8):333-40. PubMed ID: 22838251
    [Abstract] [Full Text] [Related]

  • 10. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study.
    Kim BW, Cho H, Kim H, Nam EJ, Kim SW, Kim S, Kim YT, Kim JH.
    Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):100-5. PubMed ID: 22055909
    [Abstract] [Full Text] [Related]

  • 11. Does hormonal contraception during molar pregnancy follow-up influence the risk and clinical aggressiveness of gestational trophoblastic neoplasia after controlling for risk factors?
    Dantas PRS, Maestá I, Filho JR, Junior JA, Elias KM, Howoritz N, Braga A, Berkowitz RS.
    Gynecol Oncol; 2017 Nov; 147(2):364-370. PubMed ID: 28927899
    [Abstract] [Full Text] [Related]

  • 12. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia among women with partial molar pregnancies.
    Growdon WB, Wolfberg AJ, Feltmate CM, Goldstein DP, Genest DR, Chinchilla ME, Berkowitz RS, Lieberman ES.
    J Reprod Med; 2006 Nov; 51(11):871-4. PubMed ID: 17165432
    [Abstract] [Full Text] [Related]

  • 13. Influence of hydatidiform mole follow-up setting on postmolar gestational trophoblastic neoplasia outcomes: a cohort study.
    Dantas PR, Maestá I, Cortés-Charry R, Growdon WB, Braga A, Rudge MV, Berkowitz RS.
    J Reprod Med; 2012 Nov; 57(7-8):305-9. PubMed ID: 22838246
    [Abstract] [Full Text] [Related]

  • 14. Changing presentation of complete hydatidiform mole at the New England Trophoblastic Disease Center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasia?
    Sun SY, Melamed A, Goldstein DP, Bernstein MR, Horowitz NS, Moron AF, Maestá I, Braga A, Berkowitz RS.
    Gynecol Oncol; 2015 Jul; 138(1):46-9. PubMed ID: 25969351
    [Abstract] [Full Text] [Related]

  • 15. [Value of laparoscopic surgery in the diagnosis of suspected gestational trophoblastic neoplasia cases with uterine mass].
    Li X, Feng F, Xiang Y, Wan X, Ren T, Yang J.
    Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):910-4. PubMed ID: 26887874
    [Abstract] [Full Text] [Related]

  • 16. Clinical characteristics of persistent gestational trophoblastic neoplasia after partial hydatidiform molar pregnancy.
    Feltmate CM, Growdon WB, Wolfberg AJ, Goldstein DP, Genest DR, Chinchilla ME, Lieberman ES, Berkowitz RS.
    J Reprod Med; 2006 Nov; 51(11):902-6. PubMed ID: 17165438
    [Abstract] [Full Text] [Related]

  • 17. Do we need post-pregnancy screening with human chorionic gonadotrophin after previous hydatidiform mole to identify patients with recurrent gestational trophoblastic disease?
    Earp KE, Hancock BW, Short D, Harvey RA, Fisher RA, Drew D, Sarwar N, Tidy JA, Winter MC, Chien P, Seckl MJ.
    Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():117-119. PubMed ID: 30684876
    [Abstract] [Full Text] [Related]

  • 18. Presentation, medical complications and development of gestational trophoblastic neoplasia of hydatidiform mole after intracytoplasmic sperm injection as compared to hydatidiform mole after spontaneous conception - a retrospective cohort study and literature review.
    Braga A, Andrade T, do Carmo Borges de Souza M, Campos V, Freitas F, Maestá I, Sun SY, Pedrotti LG, Bessel M, Junior JA, Filho JR, Elias KM, Horowitz NS, Berkowitz RS.
    Gynecol Oncol; 2023 Mar; 170():179-185. PubMed ID: 36706644
    [Abstract] [Full Text] [Related]

  • 19. The impact of previous cesarean section (C/S) on the risk for post-molar gestational trophoblastic neoplasia (GTN).
    Cho HW, Ouh YT, Min KJ, Lee NW, Lee S, Song JY, Hong JH, Lee JK.
    Gynecol Oncol; 2020 Mar; 156(3):606-610. PubMed ID: 31954533
    [Abstract] [Full Text] [Related]

  • 20. Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review.
    Braga A, Maestá I, Short D, Savage P, Harvey R, Seckl MJ.
    BJOG; 2016 Jul; 123(8):1330-5. PubMed ID: 26444183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.